HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

L E Wold Selected Research

Breast Neoplasms (Breast Cancer)

1/2000A prospective trial of midwest breast cancer patients: a p53 gene mutation is the most important predictor of adverse outcome.
1/2000HER-2/neu amplification in benign breast disease and the risk of subsequent breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


L E Wold Research Topics

Disease

2Cardiomegaly (Heart Hypertrophy)
09/2001 - 08/2001
2Neoplasms (Cancer)
03/2000 - 01/2000
2Breast Neoplasms (Breast Cancer)
01/2000 - 01/2000
1Neoplasm Metastasis (Metastasis)
02/2009
1Body Weight (Weight, Body)
06/2003
1Fibrosis (Cirrhosis)
08/2001
1Rheumatoid Arthritis
06/2001
1Infections
06/2001
1Sepsis (Septicemia)
06/2001
1Hypertension (High Blood Pressure)
01/2001
1Alcoholism (Alcohol Abuse)
01/2001
1Obesity
10/2000

Drug/Important Bio-Agent (IBA)

2Blood Glucose (Blood Sugar)IBA
06/2003 - 09/2001
1Insulin-Like Growth Factor I (IGF-1)IBA
06/2003
1CopperIBA
08/2001
1CytokinesIBA
06/2001
1Tumor Necrosis Factor InhibitorsIBA
06/2001
1Etanercept (Enbrel)FDA Link
06/2001
1Ethanol (Ethyl Alcohol)IBA
01/2001
1LeptinIBA
10/2000
1VimentinIBA
03/2000
1SynaptophysinIBA
03/2000
1Keratins (Keratin)IBA
03/2000
1inhibin-alpha subunitIBA
03/2000
1Indicators and Reagents (Reagents)IBA
01/2000
1Proteins (Proteins, Gene)FDA Link
01/2000

Therapy/Procedure

2Therapeutics
06/2001 - 01/2000
1Radiotherapy
02/2009
1Replacement Arthroplasty
06/2001